Home / Inspections / 1250465

FDA Inspection 1250465 — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. — FEI 2111358

The FDA completed an inspection of ANI Pharmaceuticals, Inc. on December 6, 2024 in Baudette, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 6, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baudette, MN (United States)

Facility

Other inspections at this facility

  • 1191619 (VAI Fri Nov 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1089435 (NAI Fri Apr 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983493 (NAI Thu Jul 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 852937 (NAI Fri Sep 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762035 (VAI Fri Jan 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources